News & Events

We are proud to announce that Quest Pharmaceuticals has successfully achieved ISO 27001 certification, demonstrating our commitment to the highest standards of information security. This globally recognized certification ensures that our Information Security Management System (ISMS) meets stringent security and risk management requirements, protecting our data and operations.

Quest Pharmaceuticals has launched a new drug named ‘Dfer’ to relieve patients suffering from Vitamin-D deficiency. A silent ailment, Vitamin-D deficiency is known to be widely prevalent in seemingly healthy populations in developed as well as developing countries. 

Quest Pharmaceuticals has now launched a new drug named ‘Fusid-B’ to help relieve people from dermal infections. The new medication, available as cream, helps treat a wide range of bacterial skin infections like cellulitis, folliculitis, as well as infected dermatitis (also known as eczema).

Umesh Lal Shrestha, Managing Director, Quest Pharmaceuticals has been elected Vice-President of the Federation of Nepalese Chambers of Commerce and Industries (FNCCI).

A common ailment, diabetes affects nearly 400 million people worldwide. Quest Pharmaceuticals today launched the latest medication, Lintor, to provide relief to diabetes patients in Nepal.

To help patients with the treatment of enlarged prostate resulting in dysfunctional urinary system, Quest Pharmaceuticals launched a new product named DART, today.